Results 121 to 130 of about 94,343 (260)

Keeping It Native: Non‐Denaturing Approaches to Top‐Down Protein Mass Spectrometry

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Top‐down proteomics and top‐down mass spectrometry approaches provide direct characterization of proteoforms; the specific molecular forms of proteins, including post‐translational modifications, truncations, alternative splicing, and sequence variants.
Michael Xiao   +3 more
wiley   +1 more source

Different forms of amoeba-mycobacteria interactions.

open access: yes, 2012
Different forms of amoeba-mycobacteria interactions.
Otmane Lamrabet (171689)   +2 more
core   +1 more source

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva   +23 more
wiley   +1 more source

Results of amplifiability and identification of Mycobacteria.

open access: yes, 2017
Results of amplifiability and identification of Mycobacteria.
Maja Hühns (781392)   +3 more
core   +1 more source

Boronic Acid Inhibitors of β‐Lactamases: A Promising Strategy Against Antimicrobial Resistance

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT The rise of antimicrobial resistance (AMR) poses a critical threat to global health, mostly due to the proliferation of β‐lactamases, a class of enzymes responsible for the inactivation of β‐lactam antibiotics. Among the most promising strategies to restore β‐lactam efficacy is the use of β‐lactamase inhibitors (BLIs), with boronic acid ...
Nicolò Santi   +4 more
wiley   +1 more source

Homologous recombination in mycobacteria [PDF]

open access: yes, 2004
In recent years, considerable effort and resources have been expended to develop targeted gene delivery methods, and generation of auxotrophic mutants of mycobacteria.
Chandra, Nagasuma R   +7 more
core   +1 more source

Specificity of Cut5 homologs in mycobacteria.

open access: yes, 2015
Specificity of Cut5 homologs in mycobacteria.
Vandana Gambhir (770572)   +4 more
core   +1 more source

Artificial Intelligence‐Driven Natural Product Drug Discovery: From Computational Genome Mining to Clinical Translation

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Natural products (NPs) have historically yielded numerous therapeutic agents, yet their integration into modern drug discovery has been constrained by chemical complexity, low abundance, laborious dereplication, and limited target annotation.
Antonio Lavecchia
wiley   +1 more source

Phosphatides of Atypical Mycobacteria [PDF]

open access: yes, 1968
The purpose of this investigation was to extract, separate, partially characterize and compare the individual phospholipids of the atypical ...
Hollingsworth, Russell C.
core  

Diverse Uses of Lantibiotics: Exploring New Approaches to Combat Antibiotic Resistance

open access: yesMedicine Advances, EarlyView.
This review illustrates lantibiotics as an alternative therapeutic approach to combat antibiotic resistance, highlighting their diverse sources, including plants, insects, animals, and microorganisms. It further emphasizes their broad therapeutic potential, including antibacterial, antifungal, antiparasitic, antiviral, and anticancer activities (GA ...
Gopalarethinam Janani   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy